Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy
Abstract Background Associations between mitochondrial genetic abnormalities (variations and copy number, i.e. mtDNAcn, change) and elevated ROS have been reported in cancer compared to normal cells. Since excessive levels of ROS can trigger apoptosis, treating cancer cells with ROS-stimulating agen...
Main Authors: | Tarek Zaidieh, James R. Smith, Karen E. Ball, Qian An |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08155-2 |
Similar Items
-
The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma
by: Xin Sun, et al.
Published: (2018-12-01) -
Roles of Mitochondrial DNA Damage in Kidney Diseases: A New Biomarker
by: Jun Feng, et al.
Published: (2022-12-01) -
Vanadium Pentoxide Exposure Causes Strain-Dependent Changes in Mitochondrial DNA Heteroplasmy, Copy Number, and Lesions, but Not Nuclear DNA Lesions
by: Nick L. Dobson, et al.
Published: (2023-09-01) -
Changes to the mtDNA copy number during yeast culture growth
by: Ben Galeota-Sprung, et al.
Published: (2022-07-01) -
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics
by: Sanjana Saravanan, et al.
Published: (2022-02-01)